SUP-B15 is a human Ph+ B-ALL cell line in which dasatinib strongly suppresses phosphorylation of BCR-ABL substrates and reduces proliferation in a concentration-dependent manner (12, 13). This evidence concerns the gene BCR and acute lymphoblastic leukemia.